INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?
The paper provides evidence for the clinical efficacy of infliximab, its effect on the extra-articular manifestations of rheumatoid arthritis-vasculitis, rheumatoid nodules, and cardiovascular pathology. It discusses reasons for the lower effect of therapy and the possibilities of its correction, by...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2010-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839574265619283968 |
|---|---|
| author | R M Balabanova R M Balabanova |
| author_facet | R M Balabanova R M Balabanova |
| author_sort | R M Balabanova |
| collection | DOAJ |
| description | The paper provides evidence for the clinical efficacy of infliximab, its effect on the extra-articular manifestations of rheumatoid arthritis-vasculitis, rheumatoid nodules, and cardiovascular pathology. It discusses reasons for the lower effect of therapy and the possibilities of its correction, by increasing the dose of the agent or reducing an infusion interval. |
| format | Article |
| id | doaj-art-2f3d797ea9a74b808d3ae9c891f3d43a |
| institution | Matheson Library |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2010-03-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-2f3d797ea9a74b808d3ae9c891f3d43a2025-08-04T14:00:30ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2010-03-0141616510.14412/1996-7012-2010-5891579INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?R M BalabanovaR M BalabanovaThe paper provides evidence for the clinical efficacy of infliximab, its effect on the extra-articular manifestations of rheumatoid arthritis-vasculitis, rheumatoid nodules, and cardiovascular pathology. It discusses reasons for the lower effect of therapy and the possibilities of its correction, by increasing the dose of the agent or reducing an infusion interval.https://mrj.ima-press.net/mrj/article/view/274infliximabrheumatoid arthritis |
| spellingShingle | R M Balabanova R M Balabanova INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS? Современная ревматология infliximab rheumatoid arthritis |
| title | INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS? |
| title_full | INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS? |
| title_fullStr | INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS? |
| title_full_unstemmed | INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS? |
| title_short | INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS? |
| title_sort | infliximab have all questions been answered for 10 years |
| topic | infliximab rheumatoid arthritis |
| url | https://mrj.ima-press.net/mrj/article/view/274 |
| work_keys_str_mv | AT rmbalabanova infliximabhaveallquestionsbeenansweredfor10years AT rmbalabanova infliximabhaveallquestionsbeenansweredfor10years |